 |
answer text |
<p>The United Kingdom pharmaceutical industry will play a leading role in the development
of a vaccine for the Zika virus, in collaboration with a range of the UK’s infectious
disease experts, who are world leaders in this area.</p><p> </p><p>In the Spending
Review, the £1 billion Ross Fund, run jointly by the Department of Health and Department
for International Development, includes over £350 million for the development of new
vaccines, drugs and diagnostics for infectious diseases.</p><p> </p><p>Particularly
noteworthy within this, the UK Vaccine Network, with up to £120 million of funding,
brings together industry, academia and Government to finance the development of new
vaccines for priority infectious diseases with epidemic potential, including Zika.
Indeed, the Network will launch a major funding call to finance the development of
vaccines for Zika and other priority diseases at the end of February.</p>
|
 |
